Abstract
Because of an increasing number of reports of adverse reactions associated with pharmaceutical excipients, in 1985 the Committee on Drugs issued a position statement1recommending that the Food and Drug Administration mandate labeling of over-the-counter and prescription formulations to include a qualitative list of inactive ingredients. However, labeling of inactive ingredients remains voluntary. Adverse reactions continue to be reported, although some are no longer considered clinically significant, and other new reactions have emerged. The original statement, therefore, has been updated and its information expanded.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology, and Child Health
Reference187 articles.
1. “Inactive” ingredients in pharmaceutical products.;American Academy of Pediatrics, Committee on Drugs;Pediatrics,1985
2. Incomplete labeling of pharmaceuticals: a list of “inactive” ingredients.;Brown;N Engl J Med.,1983
3. Sulfite update.;Food and Drug Administration;FDA Drug Bull.,1984
4. Sulfiting agents: revocation of GRAS status for use on fruits and vegetables intended to be served or sold raw to consumers: final rule.;Food and Drug Administration;Fed Reg,1986
5. Asthma induced by sulphur dioxide, benzoate and tartrazine contained in orange drinks.;Freedman;Clin Allergy.,1977
Cited by
116 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献